Fulgent Genetics, Inc. — Director's Dealing 2020

May 28, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Fulgent Genetics, Inc. (FLGT)
CIK: 0001674930
Period of Report: 2020-05-27

Reporting Person: Marsh Linda (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-05-27	Stock Option (Right to Buy)	$15.82	A	5000	Acquired	2030-05-26	Common Stock (5000)	Direct

Footnotes

F1: The shares subject to the option vest over a period of four years, with 1/4th of such shares vesting 12 months after May 27, 2020, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to Ms. Marsh's continued service for the Issuer on each vesting date.